Pharmacological and toxicological studies of a new non-steroidal anti-inflammatory drug: KC-8973. 1981

T Matsuo, and K Amemiya, and K Saga, and Y Hamazaki, and M Tanaka, and T Kato

A benzophenone derivative, 4-butyl-2'-fluorobenzophenone (KC-8973), having anti-inflammatory effects has been studied pharmacologically and toxicologically. On the carrageenin-induced paw edema, KC-8973 had the most potent activity of the tested commercial non-steroidal anti-inflammatory drugs. KC-8973 had a moderate effect on bradykinin-induced capillary permeability and lesser effect on dextran-, egg white- and serotonin-induced paw edemas in rats, respectively. From the detailed studies of prophylactic and therapeutic effects on the adjuvant-induced arthritis in rats, it was demonstrated that KC-8973 has an immuno-suppressive activity in addition to an anti-inflammatory effect. KC-8973 had a local-analgesic and antipyretic effect on the rat paw edema induced by brewer's yeast. KC-8973 caused no undesirable side effect at pharmacologically effective dose in the 1-month sub-acute toxicological study.

UI MeSH Term Description Entries
D008297 Male Males
D002199 Capillary Permeability The property of blood capillary ENDOTHELIUM that allows for the selective exchange of substances between the blood and surrounding tissues and through membranous barriers such as the BLOOD-AIR BARRIER; BLOOD-AQUEOUS BARRIER; BLOOD-BRAIN BARRIER; BLOOD-NERVE BARRIER; BLOOD-RETINAL BARRIER; and BLOOD-TESTIS BARRIER. Small lipid-soluble molecules such as carbon dioxide and oxygen move freely by diffusion. Water and water-soluble molecules cannot pass through the endothelial walls and are dependent on microscopic pores. These pores show narrow areas (TIGHT JUNCTIONS) which may limit large molecule movement. Microvascular Permeability,Permeability, Capillary,Permeability, Microvascular,Vascular Permeability,Capillary Permeabilities,Microvascular Permeabilities,Permeabilities, Capillary,Permeabilities, Microvascular,Permeabilities, Vascular,Permeability, Vascular,Vascular Permeabilities
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D000894 Anti-Inflammatory Agents, Non-Steroidal Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Analgesics, Anti-Inflammatory,Aspirin-Like Agent,Aspirin-Like Agents,NSAID,Non-Steroidal Anti-Inflammatory Agent,Non-Steroidal Anti-Inflammatory Agents,Nonsteroidal Anti-Inflammatory Agent,Anti Inflammatory Agents, Nonsteroidal,Antiinflammatory Agents, Non Steroidal,Antiinflammatory Agents, Nonsteroidal,NSAIDs,Nonsteroidal Anti-Inflammatory Agents,Agent, Aspirin-Like,Agent, Non-Steroidal Anti-Inflammatory,Agent, Nonsteroidal Anti-Inflammatory,Anti-Inflammatory Agent, Non-Steroidal,Anti-Inflammatory Agent, Nonsteroidal,Anti-Inflammatory Analgesics,Aspirin Like Agent,Aspirin Like Agents,Non Steroidal Anti Inflammatory Agent,Non Steroidal Anti Inflammatory Agents,Nonsteroidal Anti Inflammatory Agent,Nonsteroidal Anti Inflammatory Agents,Nonsteroidal Antiinflammatory Agents
D001577 Benzophenones Derivatives of benzophenone (with the structural formula phenyl-(C
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

T Matsuo, and K Amemiya, and K Saga, and Y Hamazaki, and M Tanaka, and T Kato
July 1986, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
T Matsuo, and K Amemiya, and K Saga, and Y Hamazaki, and M Tanaka, and T Kato
January 1985, Drugs under experimental and clinical research,
T Matsuo, and K Amemiya, and K Saga, and Y Hamazaki, and M Tanaka, and T Kato
February 1990, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
T Matsuo, and K Amemiya, and K Saga, and Y Hamazaki, and M Tanaka, and T Kato
October 1977, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
T Matsuo, and K Amemiya, and K Saga, and Y Hamazaki, and M Tanaka, and T Kato
November 1986, Japanese journal of pharmacology,
T Matsuo, and K Amemiya, and K Saga, and Y Hamazaki, and M Tanaka, and T Kato
January 1979, Arzneimittel-Forschung,
T Matsuo, and K Amemiya, and K Saga, and Y Hamazaki, and M Tanaka, and T Kato
August 1986, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
T Matsuo, and K Amemiya, and K Saga, and Y Hamazaki, and M Tanaka, and T Kato
July 1986, Methods and findings in experimental and clinical pharmacology,
T Matsuo, and K Amemiya, and K Saga, and Y Hamazaki, and M Tanaka, and T Kato
December 1984, Agents and actions,
T Matsuo, and K Amemiya, and K Saga, and Y Hamazaki, and M Tanaka, and T Kato
August 1975, Ugeskrift for laeger,
Copied contents to your clipboard!